<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03344120</url>
  </required_header>
  <id_info>
    <org_study_id>AOUCSSTURAB004</org_study_id>
    <nct_id>NCT03344120</nct_id>
  </id_info>
  <brief_title>Symptoms Comparison: Suture-stent vs Conventional Double-J Stents After Ureterorenoscopy. A Prospective Randomized Trial</brief_title>
  <official_title>Comparison Between Symptomps Related to Pigtail Suture Stent Versus Conventional Double J After Ureterorenoscopy for Stone Treatment. A Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Città della Salute e della Scienza di Torino</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double J ureteral stents (DJ) are widely used in urological practice and commonly inserted&#xD;
      after most of ureteroscopies. Stent-related symptoms (SRS) represent a major issue. Many&#xD;
      research lines have been explored with the aim of decreasing SRS: Vogt et al. projected a&#xD;
      self-made pigtail suture stent (PSS) replacing the distal pigtail with a 0.3 Fr suture&#xD;
      reaching the bladder, showing decreased SRS and good tolerance. To date, these promising&#xD;
      results hasn't been confirmed by a prospective randomized controlled trial (RCT) involving a&#xD;
      marketed PSS. Thus, we designed a prospective single-blind RCT to compare SRS caused by&#xD;
      marketed PSS and conventional DJ after uncomplicated URS for stone treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Actual">December 16, 2020</completion_date>
  <primary_completion_date type="Actual">November 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary Symptom Index Score</measure>
    <time_frame>14 days</time_frame>
    <description>to compare Urinary Symptom Index Score (sum of USSQ Urinary symptoms scores) of suture stent and double J group, 2 weeks after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>USSQ domains' scores</measure>
    <time_frame>14 days</time_frame>
    <description>to compare USSQ domains' scores of suture stent and double J group, 2 weeks after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ domains' scores</measure>
    <time_frame>2 days</time_frame>
    <description>to compare USSQ domains' scores of suture stent and double J group, 2 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ single answers</measure>
    <time_frame>14 day</time_frame>
    <description>to compare USSQ single answers of suture stent and double J group, 2 weeks after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ single answers</measure>
    <time_frame>2 days</time_frame>
    <description>to compare USSQ single answers of suture stent and double J group, 2 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2 weeks USSQ domains' subscores adjusted for baseline</measure>
    <time_frame>6 weeks</time_frame>
    <description>to compare 2 weeks USSQ domains' subscores adjusted for baseline of suture stent and double J group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications and adverse events</measure>
    <time_frame>2 weeks</time_frame>
    <description>to compare complications and adverse events of suture stent and double J group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Symptoms and Signs</condition>
  <condition>Pain</condition>
  <condition>Ureteral Calculi</condition>
  <arm_group>
    <arm_group_label>suture stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>suture stent positioning after ureteroscopy. Intervention: administration of USSQ questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional double-J stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional double-J stent positioning after ureteroscopy. Intervention: administration of USSQ questionnaire.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Administration of USSQ Symptoms questionnaire after stent positioning</intervention_name>
    <description>Administration of USSQ Symptoms questionnaire to patients with two different type of stents after ureteroscopy</description>
    <arm_group_label>conventional double-J stent</arm_group_label>
    <arm_group_label>suture stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ureteral or renal stones &lt; 2 cm needing treatment through semirigid or flexible URS&#xD;
             and laser lithotripsy&#xD;
&#xD;
          -  stone-free procedure and absence of intraprocedural complications&#xD;
&#xD;
          -  WHO performance status 0-2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant residual fragments at the end of the procedure&#xD;
&#xD;
          -  intraprocedural complications (e.g. ureteral damage or stricture)&#xD;
&#xD;
          -  indwelling double J stent&#xD;
&#xD;
          -  acute kidney failure&#xD;
&#xD;
          -  urinary tract infection&#xD;
&#xD;
          -  urinary tract abnormalities&#xD;
&#xD;
          -  pathologies or medications potentially influencing voiding pattern and pain perception&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Bosio</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Città della Salute e della Scienza di Torino</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AOU Città della Salute e della Scienza</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 11, 2017</study_first_submitted>
  <study_first_submitted_qc>November 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Città della Salute e della Scienza di Torino</investigator_affiliation>
    <investigator_full_name>Andrea Bosio</investigator_full_name>
    <investigator_title>MD Urologist, PhD</investigator_title>
  </responsible_party>
  <keyword>Symptoms and Signs</keyword>
  <keyword>Pain</keyword>
  <keyword>Ureteral Calculi</keyword>
  <keyword>Ureteroscopy</keyword>
  <keyword>Ureteral Stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

